silent atherosclerosis in young people

 A recent article found a high prevalence in individuals from 18 to 70 years old of silent atherosclerosis at 3 vascular sites: see silent atherosclerosis in young NEJM2026 in dropbox, or DOI: 10.1056/NEJMoa2609059


Details:
-- 16,808 adults aged 18-70 were enrolled in this prospective cohort study in Denmark and Spain who did not have known atherosclerotic disease and were assessed in 5 prespecified age strata 
-- silent atherosclerosis was evaluated at baseline with three-dimensional vascular ultrasonography of the carotid and femoral arteries, and with coronary computed tomographic angiography (coronary CTA) of the coronaries
-- 50.3% were recruited in Spain and  49.7% in Denmark
-- mean age 45, 51% women
-- BMI 26 (obesity 18%), systolic BP 128 mmHg, diastolic 79 mmHg
-- smoking: current 11%, former 35%; never 54%
-- lipids: LDL 3.2 mmol/L (124 mg/dL), HDL 1.5 mmol/L (58 mg/dL), triglycerides 0.9 mmol/L (80 mg/dL), lipoprotein(a) 23.1 nmol/L (2.15 mg/dL, though the medical literature is replete with concerns about the accuracy of this conversion formula, in part from the variability of the "krinkles", the apolipoprotein(a) units)
-- CRP 1.0
-- meds:
    -- antihypertensives 11%; antidiabetics 7%; lipid-lowering therapy 10%
-- family history of cardiovascular disease (CVD) 45%

-- results were adjusted for country, sex, and age, excluding collinear variables (e.g., age was not adjusted for age, sex was not adjusted for sex, etc).  Adjusted odds ratios are reported.

-- the primary outcome was the presence of silent atherosclerosis, defined as atherosclerotic plaque in at least one examined vascular territory
-- key secondary outcomes were the presence of plaque in each vascular territory, plaque volume in each territory, global peripheral plaque volume, coronary plaque volume, and coronary-artery–calcium score
    -- global peripheral plaque volume was defined as the sum of plaque volumes in the bilateral carotid and femoral arteries. Coronary plaque volume was defined as the sum of plaque volumes in the coronary arteries
    -- coronary-artery–calcium scores (CACs) were expressed in Agatston units.
Results:
Prevalence of Silent Atherosclerosis
  --Silent atherosclerosis in at least one vascular territory:
        -- present in 57.1% (56.3 to 58.0) of participants who had complete imaging
            -- men: 63.4% (62.2 to 64.6)
       -- women: 50.9% (49.7 to 52.1)
                -- 56% lower in women in the adjusted odds ratio of 0.44 (0.40 to 0.48]

-- presence by age:
            -- 18 to 29yo:
                -- men: 8.7% (6.7 to 11.1) 
                -- women: 6.7% (5.1 to 8.7)
            -- 30 to 39yo:
                -- men: 34.6% (32.2 to 37.0)
                -- women: 21.3% (19.2 to 23.5)

            -- overall age strata:
                -- adjusted odds ratio per 10-year increase:
                    -- men: 4.52 (4.21 to 4.87]
                    -- women: 3.85 (3.61 to 4.12)
                -- age-related pattern differed between men and women in prevalence of silent atherosclerosis:
                    -- men: increased starting with the stratum of 30 to 39 years, and began to plateau by midlife
                    -- women: the steepest increase occurred in the age strata after 40 years of age, narrowing the sex difference with increasing age
                    -- 60 to 70yo who had no plaque detected in any examined territory:
                        -- men: increased 1.9% (1.1 to 3.0)
                        -- women: increased 8.1% (6.4 to 10.0)

Distribution of silent atherosclerosis across vascular territories:
-- coronary-artery atherosclerosis:
    -- isolated coronary-artery atherosclerosis was uncommon among participants in every age stratum, reaching at most 9.3% (7.9 to 10.8) in men and 5.0% (4.0 to 6.1) in women.
    -- coronary-artery atherosclerosis severity and calcification increased with age in both sexes.
        -- coronary plaque was frequently present without the presence of detectable calcification, particularly in participants at younger ages
            -- among participants 30 to 39 years of age with coronary plaque, 41.8% (32.5 to 51.6) of men and 48.4% (30.2 to 66.9) of women had a coronary-artery calcium (CAC) score of 0 Agatston units
                 -- this percentage declined with age but the presence of coronary plaque without detectable calcium was still observed in adults 60 to 70 years of age

-- comparison across vascular territories:
    -- atherosclerosis in different vascular territories was strongly interrelated
    -- among participants with coronary-artery plaque, 82.0% (80.7 to 83.2) also had peripheral artery plaque, as compared with 41.5% (40.5 to 42.5) among those who did not have coronary-artery plaque
    -- the probability of coronary-artery atherosclerosis increased with greater peripheral plaque volume, with odds ratios of 1.32, 1.85, and 3.70 across increasing plaque-volume quartiles, respectively, as compared with no peripheral plaque
    -- atherosclerosis was increasingly multiterritorial with increasing age: among participants 30 to 39 years of age, two or three territories were involved in 6.0% (4.9 to 7.3) of men and 2.6% (1.8 to 3.6) of women, whereas among those 60 to 70 years of age, all three territories (coronary, femoral, and carotid) were involved in 56.3% (53.0 to 59.6) of men and 30.7% ( 27.8 to 33.7) of women
-- overall:
    --among younger participants, silent atherosclerosis was usually identified in the peripheral arteries, confined to a single vascular territory, and most often detected in the carotid arteries
    -- within the increasing age strata, combined carotid and femoral artery involvement became more common, particularly among men

this is their Figure 1 of the male/female differences in silent atherosclerosis for the different age groups:




Plaque Volume
    -- among participants with plaque, the median plaque volume was 23.9 mm3 (interquartile range, 10.2 to 58.4) in the carotid arteries, 44.8 mm3 (interquartile range, 16.0 to 120.3) in the femoral arteries, and 39.7 mm3 (interquartile range, 13.4 to 116.6) across the combined peripheral territories
    -- the median coronary-plaque volume was 74.7 mm3 (interquartile range, 32.0 to 181.4), ie much higher (and of significant concern)
    -- plaque volume increased with age, with cross sectional age-related patterns consistent with an exponential (ie more than linear) increase
    -- carotid and coronary-artery plaque volume increased more steeply with age in men than in women, whereas femoral artery plaque growth was similar between the sexes

Silent Atherosclerosis and Cardiovascular Risk Classification
-- Participants with silent atherosclerosis were of older age and had more cardiovascular risk factors and higher SCORE2 risk scores than those without plaque; these differences were greatest among participants with combined peripheral and coronary-artery atherosclerosis
    -- SCORE2 is another cardiovascular risk calculator predicting 10-year risk for people 40-69yo, with similarity to the PREVENT calculator; SCORE2 includes sex, age, smoking, systolic blood pressure, total cholesterol and HDL cholesterol, risk region (4 risk regions in Europe based on age- and sex-standardized CVD mortality rates): https://www.acc.org/latest-in-cardiology/articles/2025/02/28/14/55/updates-in-cv-disease-risk-assessment
    -- in this study, SCORE2 classification identified high 10-year risk category in only 17 participants (0.5%) with single-territory silent atherosclerosis and 97 participants (3.8%) with combined peripheral and coronary-artery silent atherosclerosis. A high SCORE2 risk was highly specific (99.8%) but had quite low sensitivity (1.9%) for silent atherosclerosis, whereas a moderate-to-high SCORE2 risk had a specificity of 87.9% and a sensitivity of 34.1%.
        -- the discordance in the SCORE2 results was most pronounced in younger participants and varied according to individual risk factors; findings were similar when participants receiving lipid-lowering or antihypertensive therapy were excluded

-- there were a total of 115 adverse events and 10 serious adverse events associated with the study procedures:
    -- 8 severe reactions to iodinated contrast material; 1 for air in contrast line; and 1 for ischemic stroke that was not felt to be related to the study procedures

-- The prevalence of silent atherosclerosis was similar in Spain and Denmark except among women 50 to 59 years of age, for whom the prevalence was lower in Spain

Commentary:

-- it has been known for many decades that atherosclerosis begins at an early age, a result that was championed by the cardiologist Valentin Fuster, citing the following:
    -- fatty streaks are in everyone aged 15-34; advanced atherosclerotic lesions in 2% men and 0% women aged 15-19; but 20% of men(!) and 8% of women aged 30-34 had advanced atherosclerotic lesions
    -- 78-97% of lesions in patients with acute coronary syndromes (ACS) had coronaries with less than 75% stenotic, half with less than 50%
    -- plaques with lipid cores >40% of volume are most vulnerable to developing ACS, since there is:
        -- active plaque disruption: inflammatory cells elaborate enzymes (metalloproteinases) which digest and weaken the fibrous cap; this cap weakening is combined with:
        -- passive plaque disruption: physical sheer stress from the passing blood over the fragile fibrous cap, leading to its disruption and exposure of cholesterol ester to the blood stream that leads to thrombosis in the artery and ACS
    -- of note, the plaques that lead to ACSs are the latter ones that are recent plaques without calcification, whereas those that cause angina are older plaques without a significant lipid core or inflammation
        -- which means that it is not surprising that coronary artery calcium scores are not great predictors of future ACS events (other than the fact that there may well be newer plaques with aging that are the ACS culprits: https://gmodestmedblogs.blogspot.com/2025/10/coronary-artery-calcium-score-pretty.html
        -- and, statins, which are strongly anti-inflammatory, actually turn younger vulnerable plaques into the older type of less vulnerable plaques and have increased coronary artery calcium scores: https://gmodestmedblogs.blogspot.com/2024/05/statins-increase-coronary-artery-calcium.html
-- this current study, with its advanced methodology, confirmed the huge prevalence of silent atherosclerosis in the population beginning in young individuals
-- of course, we deserve significant credit for this early atherosclerosis: the decades of promoting the mythology that atherosclerosis is caused by consuming lipids, therefore diets needed to be low-fat, which translates to high carbohydrates, which significantly increases the probability of obesity, diabetes, and, of course, most of the chronic conditions we are now treating in our population
-- if free of CAD at age 70, lifetime CAD risk is still 35% for men and 24% for women (ie, we should not assume that those who achieve this not-so-advanced age have escaped future cardiovascular events...., especially important in light of the fact that many 70yo people are otherwise likely to live 20+ years).

-- this study raised several issues:
    -- silent atherosclerosis was detectable in 1 in 13 participants in the study who were 18-29 years old, increasing dramatically to 9 in 10 participants by age 60-70
    -- the prevalence increased earlier in men, though later in women with a steep increase in midlife (basically occurring when menopause hits, when the protective pre-menopausal hormones decrease)
    -- the bottom line here is that men tend to develop adverse cardiovascular outcomes 5-10 years earlier than women
-- several other studies support the conclusions of this study, though the current study extended the age range further:
    -- MESA (Multi-Ethnic Study of Atherosclerosis): enrolled participants 45 to 84 years of age. about half the participants had detectable levels of coronary calcium, which predicted coronary events independent of traditional risk factors
    -- PESA (Progression of Early Subclinical Atherosclerosis) study: enrolled participants 40 to 54 years of age, finding that silent atherosclerosis in any of the following territories was present in 63% of participants: the carotid, iliac, and femoral arteries; the aorta; and the coronary arteries.
        -- plaque burden progressed over time, with modifiable risk factors most influential at younger ages
        -- SCAPIS (Swedish Cardiopulmonary Bioimage Study): enrolled participants 50 to 64 years of age, finding silent coronary-artery atherosclerosis in 42.1% of the participants and that was obstructive in 5.2%
-- and several studies have found that silent atherosclerosis predicts ischemic events and death independent of traditional cardiovascular risk factors
    -- one important conclusion of the current study is questioning the role of cardiac risk calculators, such as PREVENT and the pretty similar European SCORE-2 calculators, which do compute low risk scores in younger individuals
        -- this study found that "a high-risk or moderate-to-high–risk SCORE2 classification identified only a small minority of participants who actually had silent atherosclerosis"
        -- and, their ultimate conclusion: "conventional 10-year risk classification identified only a minority of participants with established silent atherosclerosis"
            -- this is intuitively obvious: very few asymptomatic younger people will ever have a high 10-year risk of a cardiovascular event, pretty much independent of what their risk factors are.

-- the 2026 U.S. Preventive Services Task Force (USPSTF) core recommendations for lipid screening in adults (though Health and Human Services, eg Kennedy et al, blocked publication of this recommendation and canceled 4 in-person task force meetings in a row!!):
    -- men aged 35 and older: strongly recommended for routine screening (Grade A).
    -- women aged 45 and older (increased risk): strongly recommended for screening if at increased risk for coronary heart disease (Grade A).
    -- men aged 20 to 35 (increased risk): recommended for screening if at increased risk for coronary heart disease (Grade B).
    -- women aged 20 to 45 (increased risk): recommended for screening if at increased risk for coronary heart disease (Grade B).
    -- men aged 20–35 and women aged 20+ (not at increased risk): insufficient evidence to recommend for or against routine screening (Grade C)
        -- so, these recently updated guidelines are not really different from the old ones, but this new study (and the really old studies cited above) suggest that this last recommendation may miss the boat: we should assess lipids in all in their late teens and older and provide appropriate therapy, with, i think, a persistent focus on nonpharmacologic therapy.
    -- and, as a likely embarrassment to us, the American Academy of Pediatrics is way ahead of the adult medicine guidelines, recommending that there should be universal lipid screening of all children aged 9-11 and again at age 17-21, and with testing at age 2 or older if risk factors of family history of premature cardiovascular disease, familial hypercholesterolemia, or high-risk medical conditions are present (eg, type 2 diabetes, obesity, chronic kidney disease, childhood cancer history), though from my practice, that is just about all kids.....
        -- it seems that the pediatric society was well-aware of the issue of silent atherosclerosis in teens.....

Limitations
-- there was no granular information about the specifics of smoking (how many cigarettes per day in the current smokers? when did the former smokers quit? for the latter point, the horizon of quitting time to revert to a non-smoker risk is actually in the 20-30 year range https://gmodestmedblogs.blogspot.com/2026/01/smoking-cessation-20-30yrs-to-normalize.html); diabetes (how long did individuals have diabetes, what was their control, did they use cardioprotective GLP-1 antagonists/SGLT-2s, or insulin/sulfonylureas that have been found to increase cardiac disease?); hypertension (how long were they hypertensive? what level of control?); weight/BMI (how long were they overweight, is the increased adiposity measured from visceral fat, that has a much more significant relationship with chronic systemic inflammation and heart disease: https://gmodestmedblogs.blogspot.com/2026/07/visceral-fat-loss-is-sustained-long-term.html
    -- the study demographics and related cardiovascular risk factors were baseline assessments. did they change during the course of the study?? that could affect the results
    -- and, there was no information beyond the "traditional risk factors", such as depression, stress, racial discrimination, air pollution, other environmental or occupational risk factors, etc: https://gmodestmedblogs.blogspot.com/2023/10/update-ascvd-risk-factor-critique.html
-- as with most studies, there may well be a "healthy participant" bias: those individuals who agreed with participating in studies tend to be healthier, limiting generalizability of the results
-- though the study was done in 2 different countries, the results above may not be generalizable to other countries or different areas in individual countries, since there are likely important differences in diet, exercise, having normal weight/not having increased visceral fat

so,
-- it is clear that atherosclerosis is a slowly progressive disease beginning early in life
--it is asymptomatic until it becomes symptomatic
    -- the symptomatic stage is often really terrible: 50% of people who have heart attacks do not survive; and those who do survive their heart attacks or strokes may well have sequelae (eg heart failure, paralysis) that is incredibly disabling to them and their families/supports
    -- in this context, it is really important to routinely check all adults who are in their late teens (children, younger as per above pediatric recommendations), and this should include both lipoprotein (a) and apolipoprotein B, since these confer a significantly higher atherosclerotic risk: https://gmodestmedblogs.blogspot.com/2026/09/new-pcsk9-inhibitor-pelacarsen.html
-- we cannot rely on the PREVENT or SCORE2 as used above because:
    -- the 10-year risk of a young person will essentially never reach the risk level for aggressive therapy
    -- this would include many in their 40’s
        -- the cardiovascular risk calculators include mostly the usual medical risk factors (lipids, hypertension, diabetes, overweight, smoking), but not the slew of other known ones (chronic inflammatory diseases, chronic infections, even HIV that is well-controlled, stress, racial/ethnic discrimination, depression, pollution, microplastics…..:
    -- and the protection horizon of lipid lowering by statins is in the order of 6-12 months
        -- which also means to me that since those reaching the ripe old age of 70 who have never had a cardiovascular event often should be treated if they have a life expectancy above this 6-12 month age range, since cardiovascular events are still a very common terminal event
        -- and we also know from many studies that the more risk factors increase risk in a non-linear pattern
    -- the 30-year risk calculators are hobbled by the fact that they have data from 30 years ago!! when the lifestyles were different (eg, diet with recommendations to eat carbohydrates over fats, changes in exercise being done) and the treatments were different (fewer great med for diabetes such as GLP-1s and SGLT2s and more reliance on meds that seem to increase cardiovascular risk (eg insulin, sulfonylureas)
    -- of note, the SCORE-2 risk calculator identified only a minority of participants with established silent atherosclerosis, and this should be translatable to the PREVENT risk calculator
-- bottom line: we should assume that all people older than 20 or so have atherosclerosis, and our task as clinicians/nurses/dieticians/pharmacists/other health workers should be to reinforce regularly the importance of prevention, with a priority on nonpharmacologic approaches and with meds only as needed

geoff

-----------------------------------

If you would like to be on the regular email list for upcoming blogs, please contact me at gmodest@bidmc.harvard.edu

to get access to all of the blogs:  go to http://gmodestmedblogs.blogspot.com/ to see the blogs in reverse chronological order


or you can just click on the magnifying glass on top right, then type in a name in the search box and get all the blogs with that name in them


Comments

Popular posts from this blog

air pollution and heart disease

UPDATE: ASCVD risk factor critique

visceral fat loss is sustained long-term